With 99122.0 shares changed hands, the volume of the stock remained lighter than its average volume of 0.18 million shares. During the session, the Medical Instruments & Supplies company that operates in wider Healthcare sector, reached to the highest price of $15.375 whereas the lowest price it dropped to was $15.01. The 52-week range on PLSE shows that it touched its highest point at $25.00 and its lowest point at $11.13 during that stretch. It currently has a 1-year price target of $5.00. Beta for the stock currently stands at 1.61.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of PLSE was up-trending over the past week, with a rise of 2.75%, but this was down by -13.22% over a month. Three-month performance dropped to -8.55% while six-month performance fell -13.36%. The stock lost -12.12% in the past year, while it has gained 41.27% so far this year.
Float and Shares Shorts:
At present, 67.27 million PLSE shares are outstanding with a float of 12.60 million shares on hand for trading. On 2025-06-13, short shares totaled 2.45 million, which was 364.0 higher than short shares on 1747267200. In addition to Mr. Robert W. Duggan as the firm’s Independent Co-Chairman, Mr. Paul Arthur LaViolette serves as its President, CEO, Principal Executive Officer, Principal Financial Officer & Co-Chairman of the Board.
Institutional Ownership:
Through their ownership of 0.08638 of PLSE’s outstanding shares, institutional investors have minority control over the company.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2025-03-31, PLSE reported revenue of $0.0 and operating income of -$18044000.0. The EBITDA in the recently reported quarter was -$17761000.0 and diluted EPS was -$0.25.
Analysts Ratings:
In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$0.95 being high and -$0.95 being low. For PLSE, this leads to a yearly average estimate of -$0.95.
